Inactive Instrument

MRI Interventions Inc Stock price OTC Bulletin Board

Equities

MRIC

US55347P1003

Advanced Medical Equipment & Technology

Sales 2024 * 30.26M Sales 2025 * 42.77M Capitalization 191M
Net income 2024 * -20M Net income 2025 * -19M EV / Sales 2024 * 6.3 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 4.46 x
P/E ratio 2024 *
-9.34 x
P/E ratio 2025 *
-10 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.04%
More Fundamentals * Assessed data
Dynamic Chart
Stifel Adjusts Price Target on ClearPoint Neuro to $9 From $8, Maintains Buy Rating MT
ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : ClearPoint Neuro, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Earnings Flash (CLPT) CLEARPOINT NEURO Posts Q4 Revenue $6.8M, vs. Street Est of $6.5M MT
ClearPoint Neuro, Inc. Reaffirms Revenue Guidance for the Year 2024 CI
ClearPoint Neuro, Inc. Announces Preclinical Results of an in Vivo Validation Study Have Been Published in the Journal of Neurosurgery CI
ClearPoint Neuro to Seek Acquisitions CI
ClearPoint Neuro, Inc. Announces FDA Clearance and First-In-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model CI
ClearPoint Neuro, Inc. Announces Installation and First Procedure Using the Clearpoint Prism® Neuro Laser Therapy System and Navigation System At Kaleida Health in Buffalo CI
Clearpoint Neuro Receives 510(K) Clearance for Smartframe or Stereotactic System CI
ClearPoint Neuro Shares Up 16% After Prelim. 4Q Revenue Beats Estimates DJ
Clinical Laserthermia Systems Gets SEK8 Million Order from ClearPoint Neuro; Stocks Rise MT
ClearPoint Neuro, Inc. Provides Revenue Guidance for the Full Year 2024 CI
Lake Street Cuts ClearPoint Neuro Price Target to $11 From $15, Maintains Buy Rating MT
ClearPoint Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer 47 17-11-06
Director of Finance/CFO 39 20-09-28
Chief Operating Officer 44 22-10-09
Members of the board TitleAgeSince
Director/Board Member 72 19-08-31
Director/Board Member 64 21-07-14
Chairman 78 17-05-08
More insiders
Clearpoint Neuro Inc. is a commercial-stage medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain. Its ClearPoint system is an integrated system comprised of hardware components, disposable components and intuitive, menu-driven software. Its hardware components consist primarily of a head fixation frame, computer workstation, and in-room monitor. Its disposable components for its ClearPoint system consist primarily of its SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Cannula. Its ClearPoint system software guides the physician in surgical planning, device alignment, navigation to the target and procedure monitoring. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance.
Related indices
More about the company
  1. Stock
  2. Equities
  3. Stock ClearPoint Neuro, Inc.
  4. Stock MRI Interventions Inc - OTC Bulletin Board